Ellipse Technologies, Inc. Receives CE Mark Clearance for the MAGECTM System for the treatment of Spinal Scoliosis
Ellipse Technologies, Inc. has announced that it has received CE Mark for its MAGECTM Technology for the treatment of spinal deformity. The first application for this technology is for the treatment of spinal scoliosis in young children and teenagers. The CE Mark allows the Company to market the MAGEC System in the European Union and other countries that recognize the CE Mark for commercial distribution purposes.
-
StemCor’s MarrowMiner System receives CE Mark
MAKO Receives FDA Clearance to Market Both Its Version 2.0 Tactile Guidance System(tm) and Its Bicompartmental Knee Resurfacing Implant System
CareFusion Announces National Launch Of Spinal Fracture Device
Anika Therapeutics receive Canadian regulatory approval for Monovisc
ArthroCare Receives FDA Clearance For Parallax Contour Vertebral Augmentation Device
